Search Results

Ariuka Arya is a nurse practitioner with over six years of experience as a registered nurse across adult ICU, trauma, and cardiac testing settings. She received her Bachelor of Science in Nursing from George Mason University and her Master of Science in Nursing as a family nurse practitioner from the University of Alabama at Birmingham.…

A Phase 2, Open-Label, Randomized, Global Study of Two Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer

Eileen Byrne, MSN, CRNP, is a nurse practitioner at Maryland Oncology Hematology. Eileen earned her Bachelor of Science in Nursing from Georgetown University before completing a Master of Science in Nursing at the University of Pennsylvania. She worked in oncology nursing for six years prior to joining the team at Maryland Oncology Hematology. Eileen has…

A Phase III, Open-Label, Randomized Study of Neoadjuvant Datopotamab Deruxtecan (Dato-DXd) Plus Durvalumab Followed by Adjuvant Durvalumab With or Without Chemotherapy Versus Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab With or Without Chemotherapy for the Treatment of Adult Patients with Previously Untreated Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer (D926QC00001)

Tremendous advances are made every day in the fight against cancer, but many promising treatments are costly, placing patients under enormous financial pressure. The challenges of increasing premiums, deductibles, and copayments affect many, with up to 61% of cancer patients facing difficulties in their care.1 Patients in Maryland Have a Choice in Cancer Care Today many independent…